Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Escitalopram vs. Sertraline in the Treatment of Dysthymic Disorder and Double Depression

NCT00234312 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT00234312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00234312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Escitalopram vs. Sertraline in the Treatment of Dysthymic Disorder and Double Depression
Lead sponsor
Oregon Health and Science University
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2005
Completion date
October 31, 2006
Enrollment
40
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, dysthymia